Carregant...
Epigenetic Drugs for Multiple Sclerosis
There is increasing evidence that abnormalities in epigenetic mechanisms of gene expression contribute to the development of multiple sclerosis (MS). Advances in epigenetics have given rise to a new class of drugs, epigenetic drugs. Although many classes of epigenetic drugs are being investigated, a...
Guardat en:
| Publicat a: | Curr Neuropharmacol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bentham Science Publishers
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4787283/ https://ncbi.nlm.nih.gov/pubmed/26813117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150211001600 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|